Market Size – USD 525.37 billion in 2019, Market Growth – CAGR of 11.3%, Market Trends – Increasing prevalence of chronic disorders
The growth of this market is attributed to the increase in the number of chronic diseases, which has led to the growing usage of disposable syringes. The cost-effectiveness and hassle-free procedure of the Injectable Drug Delivery devices is also an essential factor in the increasing demand for the product. Increasing research and development for the technological advancement of the devices in order to make them more convenient for the patients is augmenting the demand for the industry.
The pandemic has both a positive as well as a negative effect on the healthcare industry. It has disrupted the supply chain and raw material supplies. The increasing number of people getting affected by the virus has also led to an increase in demand for medical supplies like disposable syringes and injections. In order to meet the growing demand for medical supplies, manufactures have increased their production capacity. The manufacturers are adopting safety regulations and preventive measures without hampering the manufacturing process.
The Homecare settings segment is expected to register the highest CAGR of 11.6% over the forecast period due to the rising shift of preference among patients from hospital to home care settings. Keeping in mind the current situation of pandemic, homecare settings is one of the best services for a patient in order to prevent transmission.
North America has the highest adoption rate in the market due to the growing prevalence of chronic disorders and increasing technological innovations of the injectable drug delivery systems.
Regional Scope- North America; Europe; Asia Pacific; Central & South America; MEA
For More Details Get FREE Sample Pages of this Research Report@ https://www.emergenresearch.com/request-sample-form/112
Key participants include Terumo Corporation, Eli Lilly and Company, Becton, Dickson and Company, Pfizer, Inc., Baxter International, Inc., Schott AG, Bespak, Elcam Medical, Gerresheimer Ag, and Sandoz, among others.
Product Type Outlook (Revenue, USD Billion; 2017-2027)
Therapeutic Application Outlook (Revenue, USD Billion; 2017-2027)
End-User Outlook (Revenue, USD Billion; 2017-2027)
Helping you establish a strong foothold in the industry
The Injectable Drug Delivery report highlights set of information related to pricing and the category of customers who are more than willing to pay for certain products and services. The information on opportunities as well as product features, determine which offerings or benefits command sale and identify the communications channels used by the market leaders to create premium positioning strategies as well as attract broadest share.
Browse the full report description @ https://www.emergenresearch.com/industry-report/injectable-drug-delivery-market
The research provides answers to the following key questions:
Thank you for reading our report. For further information or queries about the report or customization options, please get in touch with us. We will ensure your report is tailored according to your requirements.
Contact Us:
Eric Lee
Corporate Sales Specialist
Emergen Research | Web: www.emergenresearch.com
Direct Line: +1 (604) 757-9756
E-mail: sales@emergenresearch.com